Bioactive properties of commercialised pomegranate (Punica granatum) juice: antioxidant, antiproliferative and enzyme inhibiting activities by Les, F et al.
See	discussions,	stats,	and	author	profiles	for	this	publication	at:	http://www.researchgate.net/publication/276297584
Bioactive	properties	of	commercialised
pomegranate	(Punica	granatum)	juice:
Antioxidant,	antiproliferative	and	enzyme
inhibiting	activities
ARTICLE		in		FOOD	&	FUNCTION	·	JUNE	2015
Impact	Factor:	2.79	·	DOI:	10.1039/C5FO00426H
READS
95
5	AUTHORS,	INCLUDING:
Jose	Maria	Prieto
University	College	London
64	PUBLICATIONS			1,182	CITATIONS			
SEE	PROFILE
Jose	M	Arbones-Mainar
Aragon	Health	Sciences	Institute
37	PUBLICATIONS			763	CITATIONS			
SEE	PROFILE
Marta	Sofía	Valero
Universidad	San	Jorge
24	PUBLICATIONS			44	CITATIONS			
SEE	PROFILE
Victor	Lopez
Universidad	San	Jorge
26	PUBLICATIONS			216	CITATIONS			
SEE	PROFILE
Available	from:	Victor	Lopez
Retrieved	on:	03	December	2015
This is an Accepted Manuscript, which has been through the 
Royal Society of Chemistry peer review process and has been 
accepted for publication.
Accepted Manuscripts are published online shortly after 
acceptance, before technical editing, formatting and proof reading. 
Using this free service, authors can make their results available 
to the community, in citable form, before we publish the edited 
article. We will replace this Accepted Manuscript with the edited 
and formatted Advance Article as soon as it is available.
You can find more information about Accepted Manuscripts in the 
Information for Authors.
Please note that technical editing may introduce minor changes 
to the text and/or graphics, which may alter content. The journal’s 
standard Terms & Conditions and the Ethical guidelines still 
apply. In no event shall the Royal Society of Chemistry be held 
responsible for any errors or omissions in this Accepted Manuscript 
or any consequences arising from the use of any information it 
contains. 
Accepted Manuscript
Food &
Function
www.rsc.org/foodfunction
View Article Online
View Journal
This article can be cited before page numbers have been issued, to do this please use:  F. Les, J. M.
Prieto, J. Arbonés-Mainar, M. Valero and V. López, Food Funct., 2015, DOI: 10.1039/C5FO00426H.
1 
 
Bioactive properties of commercialised pomegranate (Punica granatum) juice: 1 
antioxidant, antiproliferative and enzyme inhibiting activities 2 
 3 
Francisco Les 1, Jose M. Prieto 2, Jose Miguel Arbonés-Mainar 3, Marta Sofía Valero 1, 4 
Víctor López 1 * 5 
 6 
1 
Department of Pharmacy, Faculty of Health Sciences, San Jorge University, 7 
Villanueva de Gállego (Zaragoza), Spain. 8 
2 
Department of Pharmaceutical and Biological Chemistry, UCL School of Pharmacy, 9 
London, UK. 10 
3 
Adipocyte and Fat Biology Laboratory (AdipoFat), Unidad de Investigación 11 
Traslacional, Instituto Aragonés de Ciencias de la Salud (IACS), Hospital Universitario 12 
Miguel Servet, Zaragoza, Spain. 13 
 14 
*Corresponding author: Víctor López (ilopez@usj.es), Facultad de Ciencias de la Salud, 15 
Universidad San Jorge, Campus Universitario Villanueva de Gállego Autovía A-23 16 
Zaragoza-Huesca Km. 299. 50.830 Villanueva de Gállego (Zaragoza). 17 
18 
Page 1 of 24 Food & Function
Fo
od
&
Fu
nc
tio
n
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
15
 M
ay
 2
01
5.
 D
ow
nl
oa
de
d 
by
 U
N
IV
ER
SI
D
A
D
 D
E 
LA
 L
A
G
U
N
A
 o
n 
19
/0
5/
20
15
 2
1:
21
:1
3.
 
View Article Online
DOI: 10.1039/C5FO00426H
2 
 
ABSTRACT 19 
Pomegranate juice and related products have long been used either in traditional 20 
medicine or as nutritional supplements claiming beneficial effects. Although there are 21 
several studies on this food plant, only few works have been performed with 22 
pomegranate juice or marketed products. The aim of this work is to evaluate the 23 
antioxidant effects of pomegranate juice on cellular models using hydrogen peroxide as 24 
an oxidizing agent or DPPH and superoxide radicals in cell free systems. The 25 
antiproliferative effects of the juice were measured on HeLa and PC-3 cells by the MTT 26 
assay and pharmacologically relevant enzymes (cyclooxygenases, xanthine oxidase, 27 
acetylcholinesterase and monoamine oxidase A) were selected for enzymatic inhibition 28 
assays. Pomegranate juice showed significant protective effects against hydrogen 29 
peroxide induced toxicity in the Artemia salina and HepG2 models; these effects may 30 
be attributed to radical scavenging properties of pomegranate as the juice was able to 31 
reduce DPPH and superoxide radicals. Moderate antiproliferative activities in HeLa and 32 
PC-3 cancer cells were observed. However, pomegranate juice was also able to inhibit 33 
COX-2 and MAO-A enzymes. This study reveals some mechanisms by which 34 
pomegranate juice may have interesting and beneficial effects in human health. 35 
 36 
KEYWORDS: pomegranate juice, Punica granatum, ellagic acid, antioxidant, 37 
antiproliferative, COX-2, MAO-A 38 
39 
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1. Introduction 40 
Pomegranate, scientifically known as Punica granatum L. (Punicaceae), is a tree 41 
originally from the Himalayas. This species has been cultivated since antiquity in the 42 
Mediterranean and Southeast Asia, being also introduced in other areas such as tropical 43 
Africa and California1. It is a large-long lived tree, being able to reach three meters high 44 
with numerous branches. Its bark is grayish-green, bright green leaves and red flowers. 45 
The fruit is red and round, finishing in five triangular lobes, containing numerous seeds 46 
separated into groups by a membranous yellowish-white pericarp2,3. This fruit has been 47 
appreciated by numerous civilizations such as the Greek and Egyptian4, and has been 48 
used in traditional medicine, especially in Ayurvedic medicine, for the treatment of 49 
various diseases such as diarrhea, diabetes, ulcers, parasitic infections or bleeding5,6. 50 
Medicinal plants and natural products have played an important role in drug discovery. 51 
They are relatively cheap and available, and their use depends, many times, on the 52 
ancestral experience. In developing countries, traditional medicinal plants remain very 53 
important in healthcare as they are used either as medicines or nutritional supplements7. 54 
The interest in this fruit as a nutritional or medicinal product and its therapeutic 55 
applications have increased significantly in recent years due to their potential beneficial 56 
effects on health, based on the presence of antioxidants, which may protect the human 57 
body from free radicals, oxidative processes and progression of many chronic diseases8. 58 
Beverages produced from fruit juices may be an interesting source of phytochemicals 59 
and antioxidants, contributing to prevent oxidation of biomolecules such as DNA, 60 
proteins, lipids and other cellular components9,10. Pomegranate can be eaten fresh or 61 
processed into wine, juice or extracts. Several studies have shown that pomegranate has 62 
one of the highest antioxidant activity compared to other juices and extracts such as red 63 
wine, red fruits juices, citrus and tea5,11.12. 64 
Studies on the composition of pomegranate show that the main components are 65 
polyphenols, highlighting the presence of punicalagins, ellagic acid, flavonoids and 66 
anthocyanins among others13,14. 67 
Most of its biological or pharmacological properties are attributed to this high levels of 68 
polyphenols contained in pomegranate seeds. Polyphenols possess important biological 69 
functions such as antioxidant, anti-mutagenic and anti-tumor activities15,16. 70 
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Pomegranate can be considered as a functional food, and its juice may be a nutraceutical 71 
with a growing interest as an adjuvant in diseases such as atherosclerosis, whose 72 
development and progression is directly linked to oxidative processes in the 73 
cardiovascular system of the individual, being a risk factor for hypercholesterolemia, 74 
hypertension and diabetes. In addition, numerous other properties have been the focus 75 
of many studies, for instance, antimicrobial, anticancer, antiviral, antioxidant, 76 
antiproliferative, anti-parasitic or dermoprotective activities17,18,19,20. 77 
The aim of this study was to evaluate biological properties of a commercially available 78 
pure (100%, without additives) pomegranate organic juice, as many studies are 79 
performed with extracts made in the laboratory instead of registered and marketed 80 
beverages. The authors studied the antioxidant and protective effects of the juice in 81 
cellular and cell free systems, the antiproliferative effects in cancer cells (HeLa and PC-82 
3) as well as its effects on enzymes with relevant pharmacological properties such as 83 
cyclooxygenases, xanthine oxidase, acetylcholinesterase and monoamine oxidase-A. 84 
These enzymes were selected because they are involved in inflammation, uric acid 85 
formation, dementia and depression respectively. 86 
 87 
2. Materials and methods 88 
2.1. Reagents and chemicals 89 
All chemical reagents were acquired through Sigma-Aldrich (Spain). Pomegranate juice 90 
(Rabenhorst) was acquired in a specialized shop. Authors selected this product because 91 
it was organic pomegranate juice, 100% pomegranate without additives. According to 92 
the manufacturer, the juice is obtained by expression, pasteurisation and bottled into 93 
glass bottles (batch and best before 04.03.2016; 11:57). 94 
 95 
2.2. Pomegranate juice lyophilization 96 
750 ml of Rabenhorst pomegranate juice (PJ) were lyophilized using the VIRTIS 97 
Genesis 25EL lyophilizer at -40ºC (condenser at -80ºC) for 288h, with previous vacuum 98 
stage of 4 minutes until 113mTorr, and a posterior secondary drying phase of 36h with a 99 
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smooth transition of -40 to +40°C. A dried red powder was obtained and kept at -20 ºC 100 
before performing experiments. 101 
 102 
2.3. Phytochemical analyses of lyophilized pomegranate juice 103 
2.3.1. Polyphenol content 104 
Folin-Ciocalteu Assay was carried out with some modifications in order to adapt the 105 
method to 96-well plates21. 9 µl of sample was mixed with 201.5 µl of Folin-Ciocalteu 106 
reagent. After 5 min incubation at room temperature, 89.5 µl of 15% sodium carbonate 107 
was added to the mixture and this was incubated again at room temperature in the dark 108 
for 45 min. The blank wells were made with distilled water instead of Folin-Ciocalteu 109 
reagent. Absorbance was measured at 752 nm in a microplate reader. The standard 110 
curve was measured with different concentrations of gallic acid standard water solution: 111 
1, 0.5, 0.25, 0.125, 0.0625, 0.03125, 0.015625 and 0.0078125 mg/ml. The PJ water 112 
solutions were 10, 5 and 2.5 mg/ml. The result was expressed µg of gallic acid per mg 113 
of sample ± SD. 114 
2.3.2. HPLC-DAD analysis  115 
The phytochemical analysis of the lyophilized juice and the detection of the main 116 
compounds were done by HPLC using an Agilent 1260 Infinity LC (column Eclipse 117 
Plus C18 4.6 x 100 mm, 5 µm) coupled with a photodiode array detector, following a 118 
described procedure with some modifications22. Elution was carried out at a flow rate of 119 
1 ml/min using H20 (solvent A) and acetonitrile (solvent B) from 0% to 100% of solvent 120 
B in 50 min. Both solvents contained 0.5 % acetic acid. Detection was performed at 254 121 
nm. The injection volume was 10 µl and the concentration of injected sample was 10 122 
mg/ml. The presence of ellagic acid and punicalagins was confirmed by the same 123 
retention times of standard acquired in Sigma. 124 
 125 
2.4. Protective effects of pomegranate juice in living organisms and cellular models 126 
127 
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 128 
2.4.1. Protective effects of pomegranate juice against hydrogen peroxide induced 129 
toxicity in Artemia salina 130 
First of all, the toxicity of the juice was tested by the brine shrimp (Artemia salina) 131 
lethality assay23,24. Commercial dried cysts of brine shrimp were hatched in seawater 132 
with aeration for 72 hours. The lyophilized juice was dissolved in seawater and 133 
transferred to 6-well plates to obtain concentrations of 1, 10, 100, 1000 µg/ml in 5 ml 134 
sea water with 10 nauplii in each well. Control test wells were filled with 5 ml of 135 
seawater and 10 nauplii. After 24 h incubation at room temperature, the number of 136 
viable nauplii was counted. The percentage of mortality was calculated.  137 
As pomegranate juice did not affect the viability of Artemia salina nauplii within the 138 
range 1-1000 µg/ml, the same experiment was performed but hydrogen peroxide was 139 
added at a concentration of 0.4 g/L in the wells containing pomegranate juice. Control 140 
wells without treatments and shrimps exposed hydrogen peroxide were also prepared. 141 
The viability of Artemia salina nauplii was studied every 24 hour for 3 consecutive 142 
days. 143 
2.4.2. Protective effects of pomegranate juice against hydrogen peroxide induced 144 
toxicity in HepG2 cells 145 
Cultures were grown in Minimum Essential Medium (MEM) supplemented with 10% 146 
fetal bovine serum and 1% penicillin-streptomycin. Cultures were incubated in the 147 
presence of 5% CO2 at 37 ºC and 100% relative humidified atmosphere. First of all, a 148 
general cytotoxicity MTT assay was performed in order to detect non-cytotoxic doses of 149 
pomegranate juice25. Cells were seeded in 96-well microplates at a density of 7 x 103 150 
cells/ well and grown for 48 h at 37 ºC. Cells were treated with different concentrations 151 
of PJ (1-1000 µg/ml) and incubated for 24 hours. Cells were then treated with an MTT 152 
solution and incubated for 3 hours. The MTT solution was removed, formazan crystals 153 
were dissolved in DMSO and absorbance was read at 550 nm in a microplate reader. 154 
The protective effect of PJ against toxicity induced by H2O2 in HepG2 cells was carried 155 
out using the MTT assay. Cells were seeded as described above and treated with non-156 
cytotoxic concentrations of PJ (31.25, 15.62 and 3.90 µg/ml) for 24 h. HepG2 cells were 157 
then exposed to DPBS containing 500 µM H2O2 for 1 hour and new medium was added 158 
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to the cells. The MTT assay was performed 24 h after hydrogen peroxide exposure and 159 
cell survival was measured as described above. 160 
 161 
2.5. Antioxidant activity in cell free systems 162 
2.5.1. 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging capacity 163 
The capacity of the juice to scavenge DPPH free radicals was measured by a 164 
colorimetric method26. 150 µl of a DPPH methanolic solution (0.04 mg/ml) were added 165 
to 150 µl of different concentrations of PJ dissolved in water at different concentrations. 166 
Absorbance was measured at 517 nm after 30 min of reaction at room temperature in a 167 
microplate reader. Controls contained all the reaction reagents except the samples. 168 
Background interferences from solvents were deducted from the activities prior to 169 
calculating radical scavenging capacity as follows: RSC(%)= [(Abscontrol-170 
Abssample)/Abscontrol]x100 171 
The DPPH radical scavenging capacity of ellagic acid was also measured in order to 172 
compare the activity of the juice with other compounds. Ellagic acid was dissolved in 173 
ethanol. 174 
2.5.2. Superoxide radical scavenging activity 175 
Superoxide radicals were generated by the xanthine/ xanthine oxidase (X/XO) system 176 
following a described procedure27. The reaction mixture in the wells contained: 240 µl 177 
of the following mixture (90 µM xanthine, 16 mM Na2CO3, 22.8 µM NBT in phosphate 178 
buffer pH 7.0) was mixed with 30 µl sample. The reaction was initiated by the addition 179 
of the enzyme (30 µl of xanthine oxidase 168 U/L) and the mixture was incubated for 2 180 
min at 37 °C. Antioxidant activity was determined by monitoring the effect of the juice 181 
on the reduction of NBT to the blue chromogen formazan by the superoxide radical 182 
(O2
·− ) at 560 nm: RSC(%)= [(Abscontrol-Abssample)/Abscontrol]x100 183 
 184 
2.6. Antiproliferative activity in cancer cells 185 
The antiproliferative effects of PJ were screened through the MTT assay using HeLa 186 
and PC-3 cells which are common models in screening techniques25. HeLa cells were 187 
grown in DMEM supplemented with 10% fetal bovine serum and 1% penicillin-188 
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streptomycin-glutamine. PC-3 cells were grown in F-12K medium with 10% fetal 189 
bovine serum and 1% penicillin-streptomycin. Cultures were incubated in the presence 190 
of 5% CO2 at 37 ºC and 100% relative humidified atmosphere. Cells were seeded in 96-191 
well microplates at a density of 7 x 103 cells/well and grown for 24 h at 37 ºC. Cells 192 
were then treated with various concentrations of extract (0.001-1 mg/ml) for 72 h and a 193 
MTT solution was added and incubated for 3 h at 37 ºC. Cell survival was measured as 194 
reduction of MTT into formazan at 550 nm in a microplate reader. Three experiments 195 
were performed. 196 
 197 
2.7. Inhibition of enzymes with relevant pharmacological properties 198 
The following enzymes were selected because they are pharmacological targets for anti-199 
inflammatory, anti-hyperuricemic, cognitive-enhancing or antidepressant drugs.  200 
2.7.1. Inhibition of ciclooxygenases (COX-1 and COX-2) by enzyme immunoassay (EIA) 201 
The capacity of PJ to inhibit COX-1 (ovine) and COX-2 (human recombinant) was 202 
measured in terms of prostaglandin production using a commercial kit (Cayman, item 203 
No. 560131). Authors followed kit instructions. PJ was tested at two different 204 
concentrations (0.4 and 0.2 in the reaction mixture). 205 
2.7.2. Inhibition of xanthine oxidase (XO) 206 
The effect of the juice on xanthine oxidase was also evaluated by measuring the 207 
formation of uric acid from xanthine at 295 nm after 2 min. The wells contained the 208 
same components as described above in the xanthine/xanthine oxidase system but the 209 
reaction mixture did not contain 22.8 µM NBT. 210 
2.7.3. Inhibition of acetylcholinesterase (AChE) 211 
The activity was measured using a 96-microplate reader based on Ellman’s method.28 212 
Each well contained 25 µl of 15 mM ATCI in Millipore water, 125 µl of 3mM DTNB in 213 
buffer C (50 mM Tris–HCl, pH 8, 0.1 M NaCl, 0.02 M MgCl2 6 H2O), 50 µl buffer B 214 
(50 mM Tris–HCl, pH 8, 0.1% Bovine Serum), 25 µl juice in buffer A (50 mM Tris–215 
HCl, pH 8). The absorbance was read five times every 13 s for five times at 405 nm. 216 
Then, 25 µl 0.22 U/ml AChE were added and the absorbance was measured again eight 217 
times every 13 s at 405 nm.  218 
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2.7.4. Inhibition of monoamine oxidase A (MAO-A) 219 
The bioassay was performed in a 96-well microplate (Olsen et al., 2008) 29. Each well 220 
contained 50 µl juice (or appropriate solvent as control), 50 µl chromogenic solution 221 
(0.8 mM vanillic acid, 417 mM 4-aminoantipyrine and 4 U/ml horseradish peroxidase 222 
in potassium phosphate buffer pH 7.6), 100 µl 3 mM tyramine and 50 µl 8 U/ml MAO-223 
A. Absorbance was read at 490 nm every 5 min for 30 min. Background interferences 224 
were deducted as the same way described above but without MAO enzyme. Data were 225 
analyzed using GraphPad to obtain IC50 values.  226 
 227 
2.8. Statistical analysis 228 
Results are expressed as mean ± standard error of experiments performed in triplicates. 229 
Data analysis was performed using GraphPad Prism version 5. ANOVA and appropriate 230 
post hoc tests were run with data depending on the type of experiments. 231 
 232 
3. Results 233 
 234 
3.1. Phytochemical analysis of the extract by HPLC and polyphenol content 235 
Polyphenol content was measured by Folin-Ciocalteu method expressed as gallic acid 236 
equivalents (GAE). Our PJ contained 25.6 ± 0.9 µg GAE / mg of lyophilized 237 
pomegranate juice. Punica granatum juice was also analyzed by HPLC-DAD and two 238 
main peaks were detected at 254 nm. The main peaks at 1.1 min and 11.8 min were 239 
respectively identified as punicalagins and ellagic acid comparing retention times and 240 
UV-visible spectra with standards acquired in Sigma (Figure 1). 241 
 242 
3.2. Protective effects of pomegranate juice against hydrogen peroxide induced toxicity 243 
in Artemia salina 244 
As shown in Figure 2, PJ increased survival of Artemia salina nauplii compared to 0.4 245 
g/L hydrogen peroxide at 24, 48 and 72 hours. Hydrogen peroxide at 0.4 g/l induced 246 
significant toxicity at different times of the study; however, co-treatment of nauplii with 247 
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doses of 1 to 0.25 mg/ml enhances survival up to 80 - 100 % in the first 48h. At 72 h the 248 
percentage of Artemia salina survival decreases being significant only the doses of 1 249 
mg/ml. PJ was not toxic in the range 0.001-1mg/ml (data not shown). 250 
 251 
3.3. Protective effects of pomegranate juice against hydrogen peroxide induced toxicity 252 
in HepG2 cells 253 
Figure 3 shows that treating HepG2 cells with 500 µM of hydrogen peroxide for 1 hour 254 
reduced cell survival to 57.7 % compared to control. However, pre-incubation of cells 255 
with pomegranate juice at a dose of 31.25 µg/ml for 24 hours significantly increased 256 
cell viability by almost 20 % (percentage of cell survival was 78%). PJ was not toxic in 257 
the range 0.001-0.031 mg/ml in HepG2 cells. Cell viability of HepG2 was slightly 258 
reduced at higher doses (data not shown); for this reason hepatoprotective activity in 259 
HepG2 was screened at low non cytotoxic doses. 260 
 261 
3.4. Antioxidant activity in cell free systems 262 
The DPPH radicals scavenging effects of PJ and ellagic acid are shown in Figure 4. The 263 
antioxidant activity of PJ and ellagic acid is concentration dependent. IC50 values were 264 
also calculated using a nonlinear regression (one phase association) with GraphPad 265 
Prism. IC50 values were 23 µg/ml for PJ and 13 µg/mg for ellagic acid, which indicates 266 
that PJ antioxidant activity is at least in part due to the presence of this polyphenol in 267 
the juice. 268 
Figure 5 shows the antioxidant effect of PJ and ellagic acid on superoxide radical, being 269 
concentration dependent. The procedure to calculate IC50 values was the same as DPPH 270 
method. IC50 values in this case were 8 µg/ml for PJ and 12 µg/mg for ellagic acid but 271 
significant differences between the juice and ellagic acid were not detected. 272 
 273 
3.5. Antiproliferative activity in cancer cells 274 
Pomegranate juice showed dose dependent antiproliferative effects in both HeLa 275 
(cervical cancer) and PC3 (prostate cancer) cells (Figure 6). Significant differences were 276 
detected at doses over 0.125 mg/ml in HeLa whereas statistically significant differences 277 
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in PC-3 cells were detected at lower doses (0.031 mg/ml), which indicate that this cell 278 
line seems to be more sensitive to pomegranate constituents. Cell viability was similar 279 
(close to 40 %) at the highest tested dose in both cell types. 280 
 281 
3.6. Inhibition of enzymes with relevant pharmacological properties 282 
 283 
3.6.1. Inhibition of COX-1 and COX-2 284 
As shown in Figure 7, concentrations of 0.4 and 0.2 mg/ml of PJ induced COX-2 285 
inhibition of about 60% and 25% respectively. According to our date a dose-dependent 286 
effect is observed; However, PJ did not show activity on the COX-1 isoform (data not 287 
shown). 288 
 289 
3.6.2. Inhibition of XO and AChE 290 
The extract did not exert activity against these enzymes (data not shown). 291 
 292 
3.6.3 Inhibition of MAO-A 293 
Due to the fact that PJ showed a clear dose dependent MAO-A inhibition compared to 294 
other enzymes, the effects of ellagic acid and the selective MAO-A inhibitor clorgyline 295 
were studied. PJ, ellagic acid and clorgyline inhibition of MAO-A is shown in Figure 8. 296 
IC50 values were also calculated using a nonlinear regression with GraphPad Prism. IC50 297 
were 69.5 µg/ml for PJ, 0.705 µg/ml for ellagic acid and 0.024 µg/ml for clorgyline. 298 
 299 
4. Discussion 300 
Pomegranate juices and products are widely considered as a natural source of different 301 
antioxidant compounds and some studies support these claims. The antioxidant activity 302 
of this fruit is generally attributed to phytochemicals of the polyphenol type30.  303 
In our phytochemical study, total polyphenols were 25.6 ± 0.9 µg GAE / mg of 304 
lyophilized pomegranate juice (approximately 3000 mg/L), highlighting the presence of 305 
ellagic acid and punicalagins. According to the HPLC-DAD analysis, the main 306 
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polyphenolic compound was ellagic acid, followed by punicalagins. This result 307 
demonstrates that the PJ used in this study may be a good source of phenolic 308 
compounds; however, other research works show different levels of polyphenols (from 309 
144 to 10,086 mg GAE/ L) 31,32. These differences may be due to the origin of the fruit, 310 
the juice manufacturing method or how polyphenols were quantified. 311 
The protective effects of pomegranate juice (PJ) against toxicity induced by hydrogen 312 
peroxide were measured using living organisms such as Artemia salina and a cellular 313 
model based on HepG2 cells. In both cases, the juice showed significant differences 314 
versus cells or living organisms exposed to the oxidant agent. The authors performed 315 
experiments with the juice as a co-treatment with hydrogen peroxide in the case of 316 
Artemia and as a pretreatment in HepG2 cells with the aim of studying the protective 317 
effects against a common oxidant in this both situations. The highest protective effect 318 
was in the Artemia salina model of co-treatment, reaching an almost 100% survival of 319 
nauplii within 48 h. However, in HepG2 cells, the protective effect against hydrogen 320 
peroxide is 20% compared to control. This effect is consistent with other studies where 321 
oxidative stress was induced by tert-butyl hydroperoxide (t-BOOH) and treated with 322 
aqueous pomegranate seed extract33. In this case, the reduction of toxicity enhances 21 323 
% when cells were pretreated with 100 µg/mg of the extract. 324 
In the cell free systems procedures, PJ has shown great ability to reduce free radicals. 325 
The antioxidant activity of ellagic acid in cell free systems was also measured because 326 
this compound is considered to be bioavailable after oral ingestion of pomegranate juice 327 
and first pass metabolism34. The DPPH radical is widely used as a model to evaluate the 328 
antioxidant activity of compounds and extracts35. PJ has shown an ability to reduce 329 
DPPH radicals in a clear dose dependent mode of action, with an IC50 of 23 µg/ml. A 330 
recent study with pomegranate whole seed ethanolic extract (PSEE) showed antioxidant 331 
activity in the same range with an IC50 of 95.6 µg/ml
36.  In the DPPH method, IC50 of 332 
ellagic acid was lower than PJ, and therefore it may be considered that part of PJ 333 
activity was due to ellagic acid. However, in the xanthine oxidase system, IC50 values 334 
for ellagic acid and pomegranate were similar. These differences may be also due to the 335 
presence of other polyphenols, and also for the synergy of actions of these components. 336 
The xanthine oxidase system is a more relevant method of generating free radicals in 337 
biology as DPPH are artificial radicals that do not exist in physiological systems. As PJ 338 
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did not inhibit XO enzyme, we can conclude that the juice acts in this method only by 339 
capturing the superoxide radical generated by the reaction of this enzyme. This 340 
antioxidant activity is in accordance to other studies of XO and pomegranate juice37. 341 
In addition to the antioxidant activity, PJ has shown antiproliferative activity in cancer 342 
cells, referenced in several studies. In this study, authors evaluated the antiproliferative 343 
activity using the MTT assay in HeLa and PC-3 cells, which are common models in 344 
screening techniques. PJ showed dose dependent antiproliferative effects in both cell 345 
cultures. Cell viability was close to 40 % at the highest tested dose in both cell types. 346 
Other studies have reported better results in terms of antiproliferative or cytotoxic 347 
effects in cancer cell lines, where cell survival drops to 20% for both cells types too, 348 
with a treatment of pomegranate extract 36,38. These differences may be explained due to 349 
the fact that many studies are performed with concentrated and purified extracts, where 350 
as our study was done with a commercially available pomegranate juice. In this sense, 351 
in a recent study, other authors obtained significant differences in proliferation of PC-3 352 
cells between pomegranates peel extracts and seeds extracts, being almost four times 353 
higher the activity of the first extract39. These antiproliferative effects on tumor cells 354 
could be explained by the inhibition of protein kinase A, which is altered in some kind 355 
of cancers and dietary polyphenols may act as protein kinase A inhibitors40.  356 
Furthermore, our study reveals that PJ may also inhibits other enzymes with relevant 357 
pharmacological properties. The inhibition of cyclooxygenases was performed by an 358 
EIA procedure, having only significant differences on the inhibition of COX-2, which is 359 
a key enzyme for the conversion of arachidonic into prostaglandins, important 360 
inflammatory mediators. Among both isoenzymes, COX-2 is relevant in inflammatory 361 
processes, whereas COX-1 is believed to have more physiological effects. This is 362 
correlated with the studies where the extract of pomegranate fruit indicated a selective 363 
inhibition of COX-241,42.  364 
Finally, PJ also showed inhibitory effects on MAO-A, which is a key enzyme in 365 
neurotransmitters metabolism, involved in deamination of catecholamines and 366 
serotonin; inhibition of MAO-A may lead to antidepressant and anxiolytic effects and 367 
pomegranate juice caused MAO-A inhibition in a dose dependent manner, which could 368 
be a mechanism involved in the antidepressant activity of pomegranate reported in mice 369 
in previous works43,44,45. 370 
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As a conclusion, this study reveals that certain pomegranate products or beverages are 371 
an interesting source of phytochemicals with antioxidant, antiproliferative, 372 
antinflammatory or mood enhancing properties and therefore may have beneficial 373 
effects in human health. This work may help to elucidate mechanisms of action 374 
involved in properties that have been observed in previous animal or human studies 375 
performed with pomegranate products. 376 
 377 
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Figures 389 
 390 
Figure 1. HPLC profile of pomegranate juice at 254 nm. Punicalagins (1.148 min) and 391 
ellagin acid (11.821 min) were identified comparing retention times and UV-visible 392 
spectra with standards analysed by the same method. 393 
394 
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Figure 2. Protective effects of pomegranate juice (PJ) on hydrogen peroxide induced 397 
toxicity in Artemia salina. ### Significant differences (P < 0.001) were observed between 398 
control and H2O2 (0.4 g/l) samples at 24, 48 and 72 hours. 
*** Significant differences (P 399 
< 0.001) also were observed between H2O2 and H2O2+PJ samples at 24 and 48 h. At 72 400 
h only 1 mg/ml of PJ has protective effect with significant difference** (P < 0.01) 401 
compared to H2O2 samples. Significant differences were calculated through ANOVA 402 
and Dunnett´s Multiple Comparison Test. 403 
 404 
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 405 
Figure 3. Protective effects of pomegranate juice (PJ) on hydrogen peroxide induced 406 
toxicity in HepG2 cells. Results are expressed as % of cellular survival in terms of MTT 407 
reduction. * p < 0.05 versus cells exposed to 500 mM hydrogen peroxide (ANOVA and 408 
Newman Keuls Multiple comparison test). Concentration of pomegranate juice is 409 
expressed in µg/ml. 410 
411 
* 
H
2
O
2
 + PJ (µg/ml) 
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Figure 4. Antioxidant activity of pomegranate juice (PJ) and ellagic acid against DPPH 414 
radicals. IC50 values were calculated by non linear regression (23 µg/ml for PJ and 13 415 
µg/mg for ellagic acid). 416 
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Figure 5. Antioxidant activity of pomegranate juice (PJ) and ellagic acid against 418 
superoxide radicals generated by the xanthine/xathine oxidase method. IC50 values were 419 
calculated by non-linear regression (8 µg/ml for PJ and 12 µg/mg for ellagic acid). 420 
There were no significant diferences between IC50 values of pomegranate juice (PJ) and 421 
ellagic acid (Student t test) 422 
 423 
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 424 
 425 
Figure 6. Antiproliferative effects of pomegranate juice on HeLa (human cervix 426 
adenocarcinoma) and PC-3 (human prostate cancer) cells expressed as % of cell 427 
survival (% MTT reduction). * p < 0.05, ** p < 0.01 versus control (non treated cells). 428 
Significant differences were calculated through ANOVA and Dunnett´s Multiple 429 
Comparison Test. Concentrations of pomegranate juice extract on the X axis are 430 
expressed as mg/ml. 431 
* 
*** 
*** 
*** 
* 
** ** 
** 
*** 
*** 
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Figure 7. Inhibition of COX-2 by pomegranate juice. Significant differences compared 433 
to control exist for 0.4 mg/ml (P < 0.01) and 0.2 mg/ml (P < 0.05). Significant 434 
differences were calculated through ANOVA and Dunnett´s Multiple Comparison Test. 435 
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 Figure 8. MAO-A inhibition profile of pomegranate juice (PJ), ellagic acid and the 437 
selective inhibitor clorgyline. Data and IC50 values were calculated using non-linear 438 
regression representing log C inhibitor in X axis and percentage of enzyme inhibition on 439 
Y axis. 440 
441 
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